Boarding battles: Pharmacist perils in the land of limbo

Jennifer Koehl1, Marc McDowell2, Haley Fox3

  • 1Eli Lilly, Indianapolis, IN, USA.

Insights

Emergency department (ED) boarding is a critical issue impacting patient care and staff. Clinical pharmacists specializing in emergency medicine can implement interventions to improve care for boarding patients within current constraints.

Area of Science:

  • Health Services Research
  • Pharmacy Practice
  • Emergency Medicine

Background:

  • Emergency departments (EDs) face persistent overcrowding, escalating into a crisis of ED boarding.
  • ED boarding leads to ambulance diversions, delayed care, and patients leaving without treatment.
  • Consequences include medication errors, delirium, increased morbidity and mortality, and higher healthcare costs.

Purpose of the Study:

  • To address the challenges of ED boarding and its impact on patient care and outcomes.
  • To highlight the role of clinical pharmacists in mitigating ED boarding issues.
  • To detail interventions for improving care for boarding patients.

Main Methods:

  • Focus on interventions by clinical pharmacists, specifically emergency medicine pharmacists (EMPs).
  • Utilizing pharmacotherapy monitoring and management.
  • Leveraging electronic medical records and automated dispensing cabinets.

Main Results:

  • EMPs can provide continuous pharmacotherapy monitoring and management.
  • EMPs support smoother transitions of care for boarding patients.
  • EMPs can enhance electronic medical records and optimize automated dispensing cabinets.

Conclusions:

  • Clinical pharmacists, especially EMPs, are vital in addressing ED boarding challenges.
  • EMPs offer tangible interventions to improve care for boarding patients.
  • While long-term solutions require systemic reform, current workflows can be optimized by EMPs.
Abstract

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
257
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
346
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
132
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
4.2K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
109